📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
CCCL Bags New Orders Worth Rs 222 Crore in Buildings & Factories Segment
Consolidated Construction Consortium Limited (CCCL) has secured new domestic orders totaling Rs 222 Crore in January 2026. These orders pertain to the Heavy Civil Building and Buildings & Factories (B&F) verticals, covering approximately 18.12 Lakhs Sq Feet of construction. The projects are distributed across various sites in India and are scheduled for completion before the end of Financial Year 2027-2028. This influx of orders strengthens the company's order book and provides revenue visibility for the next two fiscal years.
Key Highlights
Total order value of Rs 222 Crore bagged from various domestic clients in January 2026
Project scope involves construction of 18.12 Lakhs Sq Feet under B&F and M&E divisions
Execution timeline set for completion before the end of Financial Year 2027-2028
Contracts are BOQ (Bill of Quantities) based item rate contracts across Pan India locations
💼 Action for Investors
Investors should monitor the company's execution efficiency and margin maintenance on these BOQ-based contracts. The steady order flow is a positive sign for the company's business recovery and growth trajectory.
CCL Products to Hold Q3 FY26 Earnings Conference Call on February 5, 2026
CCL Products (India) Limited has scheduled a conference call to discuss its unaudited financial results for the third quarter and nine months ended December 31, 2025. The call is slated for Thursday, February 5, 2026, at 10:00 AM IST and will be hosted by Nirmal Bang Institutional Equities. Senior management, including the Managing Director, CEO, and CFO, will be available to provide insights into the company's performance and future outlook. This is a standard procedure following the quarterly earnings release.
Key Highlights
Conference call scheduled for February 5, 2026, at 10:00 AM IST.
Focus on Q3 FY26 and nine-month financial performance ending December 31, 2025.
Management team including MD Challa Srishant and CEO Praveen Jaipuriar to participate.
Universal dial-in numbers provided: +91 22 6280 1304 and +91 22 7115 8205.
International toll-free options available for major markets including USA, UK, and Singapore.
💼 Action for Investors
Investors should review the Q3 results once published and attend the call to understand management's commentary on coffee volume growth and margin sustainability.